Beijing Tong Ren Tang Chinese Medicine Company Limited (Stock Code: 3613) has issued a notice of an Extraordinary General Meeting (EGM) scheduled for Wednesday, 11 February 2026 at 10:00 a.m. The meeting will take place at Room 1405–1409, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai, Hong Kong.

The EGM aims to consider and, if thought fit, approve the renewed distribution framework agreement entered into between the company and China Beijing Tong Ren Tang Group Co., Ltd. on 30 December 2025. The resolution also covers the proposed annual caps for the three years ending 31 December 2028.

According to the announcement, shareholders may attend in person or appoint proxies to vote on their behalf. Proxy forms must be submitted to the company’s Hong Kong share registrar and transfer office not less than 48 hours before the meeting. The register of members will be closed from 6 February 2026 to 11 February 2026, and all share transfer documents must be lodged by 4:30 p.m. on 5 February 2026.

As of the date of the notice, the board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited comprises Executive Directors Yan Han (Chairman), Yue Zheng (Vice Chairman), and Wang Chi; Non-executive Director Feng Li; and Independent Non-executive Directors Tsang Yok Sing, Jasper, Xu Hong Xi, and Chan Ngai Chi.